Orthofix Medical Inc. (OFIX)
USD 14.56
(-6.34%)
USD 14.56
(-6.34%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 93.1 Million USD | 383.95% |
| 2022 | 19.23 Million USD | -3.27% |
| 2021 | 19.89 Million USD | -10.96% |
| 2020 | 22.33 Million USD | 8.18% |
| 2019 | 20.64 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 20 Million USD | 0.0% |
| 2012 | 20 Million USD | -89.54% |
| 2011 | 191.19 Million USD | -8.39% |
| 2010 | 208.69 Million USD | -16.23% |
| 2009 | 249.13 Million USD | -10.23% |
| 2008 | 277.53 Million USD | -5.79% |
| 2007 | 294.58 Million USD | -5.6% |
| 2006 | 312.05 Million USD | 1485876.19% |
| 2005 | 21 Thousand USD | -99.97% |
| 2004 | 67.24 Million USD | -32.12% |
| 2003 | 99.07 Million USD | 225063.64% |
| 2002 | 44 Thousand USD | -94.76% |
| 2001 | 840 Thousand USD | -1.64% |
| 2000 | 854 Thousand USD | -84.12% |
| 1999 | 5.37 Million USD | 28.07% |
| 1998 | 4.2 Million USD | -55.32% |
| 1997 | 9.4 Million USD | -27.13% |
| 1996 | 12.9 Million USD | -9.79% |
| 1995 | 14.3 Million USD | 1330.0% |
| 1994 | 1 Million USD | -9.09% |
| 1993 | 1.1 Million USD | 57.14% |
| 1992 | 700 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 113.31 Million USD | -1.53% |
| 2024 Q1 | 115.07 Million USD | 23.59% |
| 2023 Q3 | 88.71 Million USD | 1.18% |
| 2023 Q1 | 64.06 Million USD | 233.01% |
| 2023 FY | 93.1 Million USD | 383.95% |
| 2023 Q2 | 87.68 Million USD | 36.85% |
| 2023 Q4 | 93.1 Million USD | 4.95% |
| 2022 Q4 | 19.23 Million USD | -0.87% |
| 2022 Q1 | 19.73 Million USD | -0.8% |
| 2022 FY | 19.23 Million USD | -3.27% |
| 2022 Q2 | 19.57 Million USD | -0.81% |
| 2022 Q3 | 19.4 Million USD | -0.84% |
| 2021 Q1 | 20.28 Million USD | -9.2% |
| 2021 Q4 | 19.89 Million USD | -0.77% |
| 2021 Q3 | 20.04 Million USD | -0.74% |
| 2021 FY | 19.89 Million USD | -10.96% |
| 2021 Q2 | 20.19 Million USD | -0.44% |
| 2020 Q3 | 22.46 Million USD | -81.66% |
| 2020 Q1 | 22.47 Million USD | 8.83% |
| 2020 Q2 | 122.5 Million USD | 445.17% |
| 2020 Q4 | 22.33 Million USD | -0.56% |
| 2020 FY | 22.33 Million USD | 8.18% |
| 2019 Q3 | 20.76 Million USD | -0.38% |
| 2019 Q1 | 20.87 Million USD | 0.0% |
| 2019 FY | 20.64 Million USD | 0.0% |
| 2019 Q4 | 20.64 Million USD | -0.57% |
| 2019 Q2 | 20.84 Million USD | -0.15% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q2 | 20 Million USD | 0.0% |
| 2014 Q3 | - USD | -100.0% |
| 2014 Q1 | 20 Million USD | 0.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 FY | 20 Million USD | 0.0% |
| 2013 Q3 | 20 Million USD | 0.0% |
| 2013 Q2 | 20 Million USD | 0.0% |
| 2013 Q1 | 20 Million USD | 0.0% |
| 2013 Q4 | 20 Million USD | 0.0% |
| 2012 Q1 | 184.94 Million USD | -3.27% |
| 2012 Q3 | 20 Million USD | -50.0% |
| 2012 Q4 | 20 Million USD | 0.0% |
| 2012 FY | 20 Million USD | -89.54% |
| 2012 Q2 | 40 Million USD | -78.37% |
| 2011 Q4 | 191.19 Million USD | -3.17% |
| 2011 FY | 191.19 Million USD | -8.39% |
| 2011 Q3 | 197.44 Million USD | -1.86% |
| 2011 Q2 | 201.19 Million USD | -1.83% |
| 2011 Q1 | 204.94 Million USD | -1.8% |
| 2010 Q4 | 208.69 Million USD | -4.02% |
| 2010 Q2 | 223.45 Million USD | -2.55% |
| 2010 FY | 208.69 Million USD | -16.23% |
| 2010 Q1 | 229.3 Million USD | -7.96% |
| 2010 Q3 | 217.44 Million USD | -2.69% |
| 2009 Q2 | 260.91 Million USD | -1.44% |
| 2009 Q3 | 255.04 Million USD | -2.25% |
| 2009 Q4 | 249.13 Million USD | -2.32% |
| 2009 FY | 249.13 Million USD | -10.23% |
| 2009 Q1 | 264.73 Million USD | -4.61% |
| 2008 Q1 | 290.06 Million USD | -1.54% |
| 2008 Q2 | 289.24 Million USD | -0.28% |
| 2008 Q4 | 277.53 Million USD | -3.76% |
| 2008 Q3 | 288.37 Million USD | -0.3% |
| 2008 FY | 277.53 Million USD | -5.79% |
| 2007 FY | 294.58 Million USD | -5.6% |
| 2007 Q1 | 307.25 Million USD | -1.54% |
| 2007 Q2 | 306.44 Million USD | -0.27% |
| 2007 Q3 | 305.58 Million USD | -0.28% |
| 2007 Q4 | 294.58 Million USD | -3.6% |
| 2006 Q3 | 326.86 Million USD | 883327.03% |
| 2006 FY | 312.05 Million USD | 1485876.19% |
| 2006 Q2 | 37 Thousand USD | 32.14% |
| 2006 Q1 | 28 Thousand USD | 33.33% |
| 2006 Q4 | 312.05 Million USD | -4.53% |
| 2005 Q1 | 59.05 Million USD | -12.18% |
| 2005 Q4 | 21 Thousand USD | -99.95% |
| 2005 Q2 | 50.91 Million USD | -13.78% |
| 2005 Q3 | 42.79 Million USD | -15.96% |
| 2005 FY | 21 Thousand USD | -99.97% |
| 2004 Q3 | 82.52 Million USD | -12.09% |
| 2004 Q4 | 67.24 Million USD | -18.51% |
| 2004 Q2 | 93.87 Million USD | -2.58% |
| 2004 Q1 | 96.36 Million USD | -2.74% |
| 2004 FY | 67.24 Million USD | -32.12% |
| 2003 Q2 | 48 Thousand USD | 4.35% |
| 2003 Q1 | 46 Thousand USD | 4.55% |
| 2003 Q4 | 99.07 Million USD | 95161.54% |
| 2003 FY | 99.07 Million USD | 225063.64% |
| 2003 Q3 | 104 Thousand USD | 116.67% |
| 2002 Q2 | 478 Thousand USD | 1.49% |
| 2002 Q4 | 44 Thousand USD | -90.13% |
| 2002 FY | 44 Thousand USD | -94.76% |
| 2002 Q3 | 446 Thousand USD | -6.69% |
| 2002 Q1 | 471 Thousand USD | -43.93% |
| 2001 Q2 | 204 Thousand USD | 44.68% |
| 2001 FY | 840 Thousand USD | -1.64% |
| 2001 Q4 | 840 Thousand USD | 0.0% |
| 2001 Q1 | 141 Thousand USD | -83.49% |
| 2000 FY | 854 Thousand USD | -84.12% |
| 2000 Q1 | 3.87 Million USD | -28.0% |
| 2000 Q2 | 2.87 Million USD | -25.82% |
| 2000 Q3 | 2.86 Million USD | -0.28% |
| 2000 Q4 | 854 Thousand USD | -70.19% |
| 1999 Q4 | 5.37 Million USD | -15.95% |
| 1999 Q2 | 2.2 Million USD | -33.33% |
| 1999 Q3 | 6.4 Million USD | 190.91% |
| 1999 FY | 5.37 Million USD | 28.07% |
| 1999 Q1 | 3.3 Million USD | -21.43% |
| 1998 Q4 | 4.2 Million USD | 0.0% |
| 1998 FY | 4.2 Million USD | -55.32% |
| 1997 FY | 9.4 Million USD | -27.13% |
| 1997 Q4 | 9.4 Million USD | 0.0% |
| 1996 Q4 | 12.9 Million USD | 0.0% |
| 1996 FY | 12.9 Million USD | -9.79% |
| 1995 Q4 | 14.3 Million USD | 0.0% |
| 1995 Q1 | 800 Thousand USD | -20.0% |
| 1995 FY | 14.3 Million USD | 1330.0% |
| 1994 Q4 | 1 Million USD | 0.0% |
| 1994 Q2 | 1.1 Million USD | 0.0% |
| 1994 FY | 1 Million USD | -9.09% |
| 1993 FY | 1.1 Million USD | 57.14% |
| 1993 Q4 | 1.1 Million USD | 0.0% |
| 1992 Q4 | 700 Thousand USD | 0.0% |
| 1992 FY | 700 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | -157.9% |
| BrainsWay Ltd. | 239 Thousand USD | -38856.904% |
| Cerus Corporation | 59.79 Million USD | -55.708% |
| Envoy Medical, Inc. | 404 Thousand USD | -22946.287% |
| electroCore, Inc. | 537 Thousand USD | -17238.361% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -775791.667% |
| IceCure Medical Ltd | 376 Thousand USD | -24662.5% |
| Inogen, Inc. | 18.27 Million USD | -409.617% |
| OrthoPediatrics Corp. | 13.45 Million USD | -591.782% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -46687.437% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -25498.256% |
| MaxCyte, Inc. | 17.96 Million USD | -418.153% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -168315.817% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| PAVmed Inc | 2.96 Million USD | -3045.507% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -1398.342% |
| RxSight, Inc. | 1.21 Million USD | -7588.439% |
| Sight Sciences, Inc. | 31.7 Million USD | -193.639% |
| SI-BONE, Inc. | 36.06 Million USD | -158.164% |
| TELA Bio, Inc. | 40.51 Million USD | -129.809% |
| Treace Medical Concepts, Inc. | 53 Million USD | -75.647% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -6021.433% |
| Acutus Medical, Inc. | 32.65 Million USD | -185.132% |
| Talis Biomedical Corporation | 16.78 Million USD | -454.671% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -2201.78% |
| CVRx, Inc. | 30.38 Million USD | -206.454% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -9055.694% |
| Bioventus Inc. | 366.99 Million USD | 74.63% |
| Venus Concept Inc. | 70.79 Million USD | -31.526% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -7384.486% |
| LivaNova PLC | 568.54 Million USD | 83.624% |
| 908 Devices Inc. | 3.92 Million USD | -2269.738% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 81.781% |
| Nemaura Medical Inc. | 3.08 Million USD | -2915.464% |
| NeuroPace, Inc. | 56.95 Million USD | -63.478% |
| LENSAR, Inc. | 1.75 Million USD | -5220.4% |
| Apyx Medical Corporation | 33.18 Million USD | -180.57% |
| Cutera, Inc. | 418.69 Million USD | 77.763% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -518.898% |
| BioSig Technologies, Inc. | 103 Thousand USD | -90295.146% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -246.071% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -835.843% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 93.73% |
| Axonics, Inc. | 25.84 Million USD | -260.321% |
| Outset Medical, Inc. | 134.59 Million USD | 30.824% |
| IRIDEX Corporation | 1.75 Million USD | -5217.362% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | -81.357% |
| IRadimed Corporation | 1.61 Million USD | -5664.854% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -52801.705% |
| INVO Bioscience, Inc. | 6.77 Million USD | -1274.053% |
| Telesis Bio, Inc. | 5.26 Million USD | -1667.072% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -1459.244% |
| Varex Imaging Corporation | 464.2 Million USD | 79.942% |
| Quipt Home Medical Corp. | 60.82 Million USD | -53.083% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -15734.524% |
| Pulmonx Corporation | 35.08 Million USD | -165.345% |
| Dynatronics Corporation | 3.25 Million USD | -2757.377% |
| Modular Medical, Inc. | 817 Thousand USD | -11296.206% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -61560.265% |
| Semler Scientific, Inc. | 70 Thousand USD | -132910.0% |
| InMode Ltd. | 6.61 Million USD | -1307.939% |
| Bruker Corporation | 1.14 Billion USD | 91.865% |
| Cytosorbents Corporation | 2.54 Million USD | -3561.511% |
| DexCom, Inc. | 2.57 Billion USD | 96.381% |
| Align Technology, Inc. | 96.96 Million USD | 3.982% |
| Viveve Medical, Inc. | 5.12 Million USD | -1717.077% |
| ZimVie Inc. | 508.79 Million USD | 81.701% |
| Movano Inc. | 15.00 USD | -620713233.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -413.694% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 76.642% |
| Profound Medical Corp. | 4.97 Million USD | -1771.716% |
| Insulet Corporation | 1.36 Billion USD | 93.186% |
| enVVeno Medical Corporation | 1.06 Million USD | -8650.658% |
| Surmodics, Inc. | 29.4 Million USD | -216.637% |
| iCAD, Inc. | 273 Thousand USD | -34005.128% |
| Nuwellis, Inc. | 221 Thousand USD | -42029.864% |
| Biotricity, Inc. | 10.85 Million USD | -757.668% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -166.401% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -14229.643% |
| InspireMD, Inc. | 1.03 Million USD | -8869.846% |
| PAVmed Inc. | 2.96 Million USD | -3045.507% |
| BIOLASE, Inc. | 13.98 Million USD | -565.763% |
| Beyond Air, Inc. | 14.72 Million USD | -532.477% |
| FONAR Corporation | 37.92 Million USD | -145.474% |
| AxoGen, Inc. | 46.6 Million USD | -99.788% |
| Vivani Medical, Inc. | 19.31 Million USD | -382.095% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | -108.704% |
| Inari Medical, Inc. | 30.35 Million USD | -206.727% |
| UFP Technologies, Inc. | 28 Million USD | -232.525% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -21351.002% |
| Tenon Medical, Inc. | 428 Thousand USD | -21653.972% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -9192.116% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -4226.172% |
| AdaptHealth Corp. | 2.09 Billion USD | 95.555% |
| Sintx Technologies, Inc. | 3.68 Million USD | -2425.278% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | -150.133% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -15734.524% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -15521.98% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 89.565% |
| TransMedics Group, Inc. | 506.2 Million USD | 81.607% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -15238.88% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -100572.541% |
| Hyperfine, Inc. | 64 Thousand USD | -145379.688% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 50.669% |
| Biomerica, Inc. | 459 Thousand USD | -20184.749% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -20614.243% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -48907.037% |
| Silk Road Medical, Inc | 75.62 Million USD | -23.115% |